Kala Pharmaceuticals Statistics Share Statistics Kala Pharmaceuticals has 6.45M
shares outstanding. The number of shares has increased by 40.04%
in one year.
Shares Outstanding 6.45M Shares Change (YoY) 40.04% Shares Change (QoQ) 5.93% Owned by Institutions (%) 65.25% Shares Floating 5.24M Failed to Deliver (FTD) Shares 300,253 FTD / Avg. Volume 259.16%
Short Selling Information The latest short interest is 320.16K, so 4.96% of the outstanding
shares have been sold short.
Short Interest 320.16K Short % of Shares Out 4.96% Short % of Float 6.32% Short Ratio (days to cover) 1.77
Valuation Ratios The PE ratio is -0.99 and the forward
PE ratio is -2.2.
Kala Pharmaceuticals's PEG ratio is
0.02.
PE Ratio -0.99 Forward PE -2.2 PS Ratio 0 Forward PS 1.8 PB Ratio 3.11 P/FCF Ratio -1.29 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kala Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.11,
with a Debt / Equity ratio of 2.62.
Current Ratio 3.11 Quick Ratio 3.11 Debt / Equity 2.62 Debt / EBITDA -0.79 Debt / FCF -1.09 Interest Coverage -7.09
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.01M Employee Count 38 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 20.81% in the
last 52 weeks. The beta is -1.82, so Kala Pharmaceuticals's
price volatility has been lower than the market average.
Beta -1.82 52-Week Price Change 20.81% 50-Day Moving Average 5.48 200-Day Moving Average 6.03 Relative Strength Index (RSI) 58.19 Average Volume (20 Days) 115,856
Income Statement
Revenue n/a Gross Profit n/a Operating Income -40.98M Net Income -38.51M EBITDA -40.98M EBIT -44.29M Earnings Per Share (EPS) -6.98
Full Income Statement Balance Sheet The company has 51.18M in cash and 32.25M in
debt, giving a net cash position of 18.93M.
Cash & Cash Equivalents 51.18M Total Debt 32.25M Net Cash 18.93M Retained Earnings -667.92M Total Assets 48.25M Working Capital 22.74M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.38M
and capital expenditures -208K, giving a free cash flow of -29.59M.
Operating Cash Flow -29.38M Capital Expenditures -208K Free Cash Flow -29.59M FCF Per Share -5.36
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KALA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for KALA is $13.5,
which is 89.1% higher than the current price. The consensus rating is "Buy".
Price Target $13.5 Price Target Difference 89.1% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 21, 2022. It was a
backward
split with a ratio of 1:50.
Last Split Date Oct 21, 2022 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -20.67 Piotroski F-Score 2
